感染和炎症显像剂的研究与应用

楚进锋; 王学斌

感染和炎症显像剂的研究与应用

楚进锋 , 王学斌

文章导航 > 国际放射医学核医学杂志 > 2002, 26 > 5: (200-204)

引用本文:

Citation:

感染和炎症显像剂的研究与应用

100875 北京, 北京师范大学化学系

作者简介: 楚进锋(1977-),男,河南商丘人,博士研究生,主要从事医用放射性药物化学的研究;王学斌(1939-),男,天津人,博士生导师,主要从事医用放射性药物化学的研究。;

中图分类号: R817.4

Study and application of imaging agents for infection and inflammation

Department of Chemistry, Beijing Normal University, Beijing 100875, China
CLC number: R817.4

摘要: 综述了目前主要炎症显像剂的研究与临床应用情况,主要包括标记的小分子化合物、白细胞、大分子蛋白、脂质体、抗生素和生物素等。
- 感染 /
- 炎症 /
- 显像剂
Abstract: Situation of current study and clinic application of main imaging agents for infection and inflammation is summarized.These agents include radiolabelled small molecular compounds,leucocytes,large molecular proteins,liposomes,antibiotics,biotins and etc.
- infection /
- inflammation /
- imaging agents
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Boerman OC, Dams ETM, Oyen WJG, et al. Radiopharmaceuticals for scintigraphic imaging of infection and inflammation[J]. Inflamm Res, 2001, 50:55-64.
[2]	Ercan MT, Unlenen E. Accumulation of some small molecular weight complexes of ⁹⁹Tc^m in experimental abscesses[J]. Nucl Med Biol, 1994, 21(2):143-149.
[3]	Datz FL. Abdominal abscess detection:gallium, ¹¹¹In, and ⁹⁹Tc^m-labelled leukocytes, and polyclonal and monoclonal antibodies[J]. Semin Nucl Med, 1996, 26(1):51-64.
[4]	Rennen HJJM, Boerman OC, Oyen WJG, et al. Imaging infection/inflammation in the new millennium[J]. Eur J Nucl Med, 2001, 28(2):241-252.
[5]	Babich JW, Graham W, Barrow SA, et al. Technetium-99m-labelled chemotactic peptide:comparison with indium-111-labelled white blood cells for localizing acute bacterial infection in the rabbit[J]. J Nucl Med, 1993, 34:2176-2181.
[6]	Pollak A, Goodbody AE, Ballinger JR, et al. Imaging inflammation with ⁹⁹Tc^m-labelled chemotactic peptides:analogues with reduced neutropenia[J]. Nucl Med Commun,1996, 17:132-139.
[7]	Rusckowski M, Qu T, Pullman J, et al. Inflammation and infection imaging with a ⁹⁹Tc^m-neutrophil elastase inhibitor in monkeys[J]. J Nucl Med, 2000, 41:363-374.
[8]	Caveliers V, Goodbody AE, Tran LL, et al. Evaluation of ⁹⁹Tc^m-RP128 as a potential inflammation imaging agent:human dosimetry and first clinical results[J]. J Nucl Med, 2001, 42:154-161.
[9]	Babich JW, Tompkins RG, Graham W, et al. Localization of radiolabeled chemotactic peptide at focal sites of Escherichia coli infection in rabbits:evidence for a receptorspecific mechanism[J]. J Nucl Med, 1997, 38:1316-1322.
[10]	van der Laken CJ, Boerman OC, Oyen WJG, et al. Imaging of infection in rabbits with radioiodinated interleukin-1(α and β), its receptor antagonist and a chemotactic peptide:a comparative study[J]. Eur J Nucl Med, 1998, 25(4):347-352.
[11]	Chianelli M, Signore A, Fritzberg AR, et al. The development of technetium-99m-labelled interleukin-2:a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseases[J]. Nucl Med Biol, 1997, 24:579-586.
[12]	Rennen HJJM, Boerman OC, Oyen WJG, et al. Specific and rapid scintigraphic detection of infection with ⁹⁹Tc^m-labelled interleukin-8[J]. J Nucl Med, 2001, 42:117-123.
[13]	Moyer BR, Vallabhajosula S, Lister-James J, et al. Technetium-99m-white blood cell-specific imaging agent developed from platelet factor 4 to detect infection[J]. J Nucl Med, 1996, 37:673-679.
[14]	Britton KE, Vinjamuri S, Hall AV, et al. Clinical evaluation of technetium-99m infection for the localisation of bacterial infection[J]. Eur J Nucl Med, 1997, 24(5):553-556.

[1]	李林法 . ¹⁸F-氟代脱氧葡萄糖正电子发射体层显像在感染与炎症病变中的应用. 国际放射医学核医学杂志, 2006, 30(1): 26-29.
[2]	赵春雷 , 栗维国 , 罗锡圭 , 李亚明 . 核医学炎症显像对临床炎症性疾病的评价. 国际放射医学核医学杂志, 1996, 20(6): 250-254.
[3]	曹国祥 , 谭天秩 . 多巴胺受体显像剂的研究概况. 国际放射医学核医学杂志, 1999, 23(2): 65-67.
[4]	莫纯威 , 徐万帮 , 唐刚华 . 靶向成纤维细胞活化蛋白PET显像剂的研究进展. 国际放射医学核医学杂志, 2022, 46(12): 735-741. doi: 10.3760/cma.j.cn121381-202203029-00251
[5]	郑晨曦 , 潘东风 , 袁耿彪 . 白细胞核素显像探针的临床应用和研究进展. 国际放射医学核医学杂志, 2018, 42(3): 286-290. doi: 10.3760/cma.j.issn.1673-4114.2018.03.017
[6]	贾路路 , 郭昆冈 , 唐红军 , 付巍 . 阿尔茨海默病相关正电子显像剂的研究进展. 国际放射医学核医学杂志, 2023, 47(3): 190-195. doi: 10.3760/cma.j.cn121381-202209012-00279
[7]	梁欢 , 王政杰 , 李梦丹 , 敬兴果 . ¹⁸F-FDG PET/CT参数和炎症标志物在鼻咽癌预后预测中的应用进展. 国际放射医学核医学杂志, 2024, 48(2): 123-129. doi: 10.3760/cma.j.cn121381-202304014-00392
[8]	万建美 , 范我 . 动脉粥样硬化斑块核素显像研究进展. 国际放射医学核医学杂志, 2007, 31(1): 17-20.
[9]	修雁 , 陈绍亮 . 近年来对⁶⁷Ga临床应用的认识. 国际放射医学核医学杂志, 1998, 22(2): 66-68.
[10]	孟媛媛 , 杨福军 , 徐文清 . 乏氧诱导因子在疾病中作用机制的研究进展. 国际放射医学核医学杂志, 2017, 41(5): 347-352. doi: 10.3760/cma.j.issn.1673-4114.2017.05.008
[11]	杨建权 , 李晔 , 张现忠 . 基于小分子肽的放射性药物. 国际放射医学核医学杂志, 2003, 27(4): 157-161.